P2Y6 receptor potentiates pro-inflammatory responses in macrophages and exhibits differential roles in atherosclerotic lesion development

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Garcia, Ricardo A ^a   Yan, Mujing ^a   Search, Debra ^a   Zhang, Rongan ^a   Carson, Nancy L ^a   Ryan, Carol S ^a   Smith Monroy, Constance ^a   Zheng, Joanna ^a   Chen, Jian ^a   Kong, Yan ^a   Tang, Huaping ^a   Hellings, Samuel E ^a   Wardwell Swanson, Judith ^a   Dinchuk, Joseph E ^a   Psaltis, George C ^a   Gordon, David A ^a   Glunz, Peter W ^a   Gargalovic, Peter S ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN GRO1; PURINERGIC P2Y6 RECEPTOR; RECEPTOR PROTEIN; UNCLASSIFIED DRUG; CYTOKINE; LOW DENSITY LIPOPROTEIN RECEPTOR; PURINERGIC P2 RECEPTOR;

ABDOMINAL AORTA ANEURYSM; ANEURYSM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOMA CELL; ATHEROGENESIS; ATHEROSCLEROSIS; BLASTOCYST; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EMBRYO; EXON; FEMALE; HUMAN; HUMAN CELL; MACROPHAGE; MALE; MOUSE; NONHUMAN; OPEN READING FRAME; P2Y6 RECEPTOR GENE; PHENOTYPE; PRIMARY CELL CULTURE; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR GENE; ANIMAL; C57BL MOUSE; DEFICIENCY; GENE INACTIVATION; GENETICS; IMMUNOLOGY; INFLAMMATION; METABOLISM; SECRETION (PROCESS); TUMOR CELL LINE;

ANIMALS; ATHEROSCLEROSIS; CELL LINE, TUMOR; CYTOKINES; FEMALE; GENE KNOCKOUT TECHNIQUES; HUMANS; INFLAMMATION; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; PHENOTYPE; RECEPTORS, LDL; RECEPTORS, PURINERGIC P2;

EID: 84909987306     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0111385     Document Type: Article

References (31)

1. Moore KJ, Tabas I (2011) Macrophages in the pathogenesis of atherosclerosis. Cell 145: 341-355.
2. Rubartelli A, Lotze MT (2007) Inside, outside, upside down: damage-associated molecular-pattern molecules (DAMPs) and redox. Trends Immunol 28: 429-436.
3. Junger WG (2011) Immune cell regulation by autocrine purinergic signalling. Nat Rev Immunol 11: 201-212.
4. Guns PJ, Hendrickx J, Van Assche T, Fransen P, Bult H (2010) P2Y receptors and atherosclerosis in apolipoprotein E-deficient mice. Br J Pharmacol 159: 326-336.
5. Lattin JE, Schroder K, Su AI, Walker JR, Zhang J, et al. (2008) Expression analysis of G Protein-Coupled Receptors in mouse macrophages. Immunome Res 4: 5.
6. Warny M, Aboudola S, Robson SC, Sevigny J, Communi D, et al. (2001) P2Y(6) nucleotide receptor mediates monocyte interleukin-8 production in response to UDP or lipopolysaccharide. J Biol Chem 276: 26051-26056.
7. Kukulski F, Ben Yebdri F, Lefebvre J, Warny M, Tessier PA, et al. (2007) Extracellular nucleotides mediate LPS-induced neutrophil migration in vitro and in vivo. J Leukoc Biol 81: 1269-1275.
8. Cox MA, Gomes B, Palmer K, Du K, Wiekowski M, et al. (2005) The pyrimidinergic P2Y6 receptor mediates a novel release of proinflammatory cytokines and chemokines in monocytic cells stimulated with UDP. Biochem Biophys Res Commun 330: 467-473.
9. Kim B, Jeong HK, Kim JH, Lee SY, Jou I, et al. (2011) Uridine 5′-diphosphate induces chemokine expression in microglia and astrocytes through activation of the P2Y6 receptor. J Immunol 186: 3701-3709.
10. Riegel AK, Faigle M, Zug S, Rosenberger P, Robaye B, et al. (2011) Selective induction of endothelial P2Y6 nucleotide receptor promotes vascular inflammation. Blood 117: 2548-2555.
11. Bar I, Guns PJ, Metallo J, Cammarata D, Wilkin F, et al. (2008) Knockout mice reveal a role for P2Y6 receptor in macrophages, endothelial cells, and vascular smooth muscle cells. Mol Pharmacol 74: 777-784.
12. Kauffenstein G, Drouin A, Thorin-Trescases N, Bachelard H, Robaye B, et al. (2010) NTPDase1 (CD39) controls nucleotide-dependent vasoconstriction in mouse. Cardiovasc Res 85: 204-213.
13. Wattler S, Kelly M, Nehls M (1999) Construction of gene targeting vectors from lambda KOS genomic libraries. BioTechniques 26: 1150-1156, 1158, 1160.
14. Garcia RA, Search DJ, Lupisella JA, Ostrowski J, Guan B, et al. (2013) 11beta-hydroxysteroid dehydrogenase type 1 gene knockout attenuates atherosclerosis and in vivo foam cell formation in hyperlipidemic apoE(-)/(-) mice. PloS one 8: e53192.
15. Seager Danciger J, Lutz M, Hama S, Cruz D, Castrillo A, et al. (2004) Method for large scale isolation, culture and cryopreservation of human monocytes suitable for chemotaxis, cellular adhesion assays, macrophage and dendritic cell differentiation. J Immunol Methods 288: 123-134.
16. El-Tayeb A, Qi A, Muller CE (2006) Synthesis and structure-activity relationships of uracil nucleotide derivatives and analogues as agonists at human P2Y2, P2Y4, and P2Y6 receptors. J Med Chem 49: 7076-7087.
17. Schwartz D, Andalibi A, Chaverri-Almada L, Berliner JA, Kirchgessner T, et al. (1994) Role of the GRO family of chemokines in monocyte adhesion to MM-LDL- stimulated endothelium. The Journal of clinical investigation 94: 1968-1973.
18. Boring L, Gosling J, Cleary M, Charo IF (1998) Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394: 894-897.
19. Ait-Oufella H, Taleb S, Mallat Z, Tedgui A (2011) Recent advances on the role of cytokines in atherosclerosis. Arteriosclerosis, thrombosis, and vascular biology 31: 969-979.
20. Uratsuji H, Tada Y, Kawashima T, Kamata M, Hau CS, et al. (2012) P2Y6 receptor signaling pathway mediates inflammatory responses induced by monosodium urate crystals. J Immunol 188: 436-444.
21. Linton MF, Atkinson JB, Fazio S (1995) Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation. Science 267: 1034-1037.
22. Daugherty A, Cassis L (1999) Chronic angiotensin II infusion promotes atherogenesis in low density lipoprotein receptor -/- mice. Annals of the New York Academy of Sciences 892: 108-118.
23. Daugherty A, Manning MW, Cassis LA (2000) Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. The Journal of clinical investigation 105: 1605-1612.
24. Boisvert WA, Santiago R, Curtiss LK, Terkeltaub RA (1998) A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice. The Journal of clinical investigation 101: 353-363.
25. Gu L, Okada Y, Clinton SK, Gerard C, Sukhova GK, et al. (1998) Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Molecular cell 2: 275-281.
26. Boisvert WA, Curtiss LK (1999) Elimination of macrophage-specific apolipoprotein E reduces diet-induced atherosclerosis in C57BL/6J male mice. Journal of lipid research 40: 806-813.
27. Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, Suzuki Y, et al. (2001) Role of the renin-angiotensin system in vascular diseases: expanding the field. Hypertension 38: 1382-1387.
28. Rowe VL, Stevens SL, Reddick TT, Freeman MB, Donnell R, et al. (2000) Vascular smooth muscle cell apoptosis in aneurysmal, occlusive, and normal human aortas. Journal of vascular surgery 31: 567-576.
29. Wang YX, Martin-McNulty B, da Cunha V, Vincelette J, Lu X, et al. (2005) Fasudil, a Rho-kinase inhibitor, attenuates angiotensin II-induced abdominal aortic aneurysm in apolipoprotein E-deficient mice by inhibiting apoptosis and proteolysis. Circulation 111: 2219-2226.
30. Hou M, Harden TK, Kuhn CM, Baldetorp B, Lazarowski E, et al. (2002) UDP acts as a growth factor for vascular smooth muscle cells by activation of P2Y(6) receptors. Am J Physiol Heart Circ Physiol 282: H784-792.
31. Schiller NK, Kubo N, Boisvert WA, Curtiss LK (2001) Effect of gamma-irradiation and bone marrow transplantation on atherosclerosis in LDL receptor-deficient mice. Arteriosclerosis, thrombosis, and vascular biology 21: 1674-1680.